seqWell was created to revolutionize NGS library prep to unlock the full potential of today's DNA sequencing instruments. Building on core strengths of molecular reagent design and workflow engineering, seqWell's product portfolio allows improvements in the scale and quality of DNA sequencing results. Our plexWell™ platform is a transformative library prep technology that allows for simple, scalable multiplexing of 100s to 1000s of samples without time- and cost-consuming normalization. plexWell has wide-ranging impact on applications from synthetic biology, targeted sequencing and single-cell analysis to low and high depth sequencing of human, plant, animal and microbial genomes.

In addition to plexWell, seqWell is also developing library prep methods for reagent-based approaches for long-molecule phasing and read linking.

Management

ABOUT

Joseph Mellor, PhDFounder and Chief Executive Officer

ABOUT

Jack T. Leonard, PhDChief Technology Officer

ABOUT

Tom GrantChief Financial Officer

ABOUT

Chris BoggessVP, Commercialization

ABOUT

Ariele Hanek, PhDDirector, Research and Development

Scientific Advisors

ABOUT

Fritz Roth, PhDProfessor, University of Toronto

ABOUT

Corey Nislow, PhDProfessor, University of British Columbia

ABOUT

Marc Vidal, PhDProfessor, Harvard Medical School and Dana-Farber Cancer Institute